跳至主要内容
临床试验/IRCT20081110001444N6
IRCT20081110001444N6已完成3 期

The Efficacy of Silymarin and Vitamin E in the Treatment of the Non-Alcoholic Fatty Liver Disease: A Clinical Trial

Shahid Sadoughi University of Medical Sciences-Yazd, Iran0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • The inclusion criteria were : NAFLD confirmed through abdominal ultrasonography, persistent elevation in the level of alanine aminotransferase (ALT) within the last six months for one and a half times more than the upper normal limit, fatty changes diagnosed through ultrasonography, and over 20 years of age.

排除标准

  • The exclusion criteria were autoimmune hepatitis, alpha-1 antitrypsin deficiency, chronic hepatitis B or C, hemochromatosis, and Wilson’s disease. Patients with a history of diabetes, daily consumption ethanol, severe cardiac, pulmonary, renal, or psychological problems, positive pregnancy test, and the use of drugs such as statins, fibrates, anti-convulsants, NSAID, acetaminophen, warfarin, metronidazole, anti-depressants, or anti-psychotics were also excluded from the study.

研究者

发起方
Shahid Sadoughi University of Medical Sciences-Yazd, Iran

相似试验